References
Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 35:349–356
Dalen AB, Hellgren L, Iversen OJ, Vincent J (1983) A virus-like particle associated with psoriasis. Acta Pathol Microbiol Immunol Scand B 91:221–229
Iversen OJ (1983) Isolation of virus-like particles in urine from a psoriatic patient. Acta Pathol Microbiol Immunol Scand B 91:407–12
Åsbakk K, Iversen OJ (1988) Monoclonal antibodies against the major internal protein, p27, of a psoriasis-associated retrovirus-like particle. Scand J Immunol 28:195–201
Iversen OJ, Lysvand H, Jacobsen T, Bergh K, Lie BA (1995) The psoriasis-associated antigen, pso p27, is expressed by tryptase-positive cells in psoriatic lesions. Arch Dermatol Res 287:503–505
Iversen OJ, Lysvand H, Bergh K, Eriksen J, Elsayed S (1995) The N-terminal amino acid sequence of the psoriasis-associated antigen, pso p27. Arch Dermatol Res 287:761–763
Dalaker M, Jacobsen T, Lysvand H, Iversen OJ (1999) Expression of the psoriasis-associated antigen, pso p27, is inhibited by cyclosporine A. Acta Derm Venereol 79:281–284
Asbakk K, Bergh K, Iversen OJ (1990) The psoriasis-associated antigen, pso p27, participates in the formation of complement activating immune-complexes in psoriatic scale. APMIS 98:143–149
Takeda A, Higuchi D, Takahashi T, Ogo M, Baciu P, Goetinck PF, Hibino T (2002) Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin. J Invest Dermatol 118:147–154
Townsend BL, Cohen PR, Duvic M (1995) Zidovudine for the treatment of HIV-negative patients with psoriasis: a pilot study. J Am Acad Dermatol 32:994–999
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, X., Ikeda, S., Yaguchi, H. et al. An anti-pso p27 monoclonal antibody reacts with skin and peripheral blood leukocytes from Japanese psoriatic patients and shows cross-reactivity with SCCA2b. Arch Dermatol Res 296, 372–374 (2005). https://doi.org/10.1007/s00403-004-0530-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-004-0530-z